HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 08, August 2017 – Eye – the Window to your Soul       » Palm-Sized PCR Device for Rapid Real-Time Detection of Viruses       » Scientists Uncover New Mechanism for Diabetic Neuropathy       » China Enlists AI to Diagnose Breast Cancer       » Philips and Singapore Institute of Advanced Medicine Holdings Sign Agreement to Open First-of-its-kind Oncology Center in Singapore       » Guardian Partners with MyDoc to Address Singapore's Population Health Needs through Integrating Technology and Self-Care       » Database Boosts Shanghai's Technology Aim      
EYE ON CHINA
Abcam to open office in Shanghai, China
Abcam plc, a global leader in the supply of innovative protein research tools, will open a new office in Shanghai, China. The new hub is the Company's ninth global office, and has been established to support Abcam's focus on increasing geographic reach and improving distribution channels to rapidly growing markets. Located in Zhangjiang Hi-Tech Park, Pudong New District, a prominent economic growth and innovation area, the office is within close proximity of the City and Abcam's production facility in Hangzhou, which develops pioneering research tools such as RabMAbTM, its proprietary rabbit monoclonal antibody technology.

The office will house customer and technical support functions, provided by native Mandarin speakers, as well as a product warehouse, which will facilitate local stock storage for the first time. This means that customers will benefit from improved delivery times, with the large majority of orders arriving at their door within 24 hours. The proximity of the office will also enable Abcam to support customers with more specific needs through its extensive range of products and services, including custom antibody production.

Dr Jonathan Milner, CEO, Abcam, said: "China is an important market for Abcam and we're pleased to provide enhanced services such as faster delivery and dedicated local language support to our customers. Further future investments will ensure we continue to deliver innovative products and services to enable scientists to discover more."

Click here for the complete issue.

NEWS CRUNCH  
news Vitafoods Asia 2017 heralds a new future of innovation
news Sanner receives Zero Defect Award
news AdAlta pioneers novel drug for rare lung disease
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye – the Window to your Soul
September:
Emerging Infectious Diseases
October:
No. 1 Killer — Heart Diseases
November:
Diseases threatening our Children
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy